Cleanser
NDC Package 51439-005-01
Package Information
Cleanser is directions:cleanse skin with ACNE CLEARING CLEANSER a benzoyl peroxide acne medication cleansing gel.moisten fresh cotton ball with ACNE CLEARING TONIC a salicylic acid serum medication for oil control.apply ACNE CLEARING TREATMENT 101 a sulphur and natural anti-inflammatory lotion medication to acne breakout areas.start with one application daily then gradually increase to 2 or 3.if going outside after cleansing apply sun screen, Acne Clearing Moisture with SPF 45if excessive irritation or sensitivity develops stop use of both products and contact a physician. Marketed by Carepluss Pharma S.a. De C.v., this product is identified by NDC 51439-005 and is authorized under FDA application part333D.
Identification & Billing
- RxCUI: 845836 - benzoyl peroxide 2.5 % Medicated Liquid Soap
- RxCUI: 845836 - benzoyl peroxide 25 MG/ML Medicated Liquid Soap
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51439 - Carepluss Pharma S.a. De C.v.
- 51439-005 - Cleanser
- 51439-005-01 - .024 mg in 1 BOTTLE
- 51439-005 - Cleanser
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51439-005-01 identifies a specific commercial package of .024 mg in 1 bottle of Cleanser Acne Clearing Treatment, labeled by Carepluss Pharma S.a. De C.v.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Carepluss Pharma S.a. De C.v. on August 06, 2012. The current certification is valid through December 31, 2017.
How is this Carepluss Pharma S.a. De C.v. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51439000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.